Maribrook Tablet(Maribavir)
Maribrook Tablet contains maribavir, a novel antiviral agent specifically indicated for the treatment of cytomegalovirus (CMV) infection in patients who are resistant or refractory to conventional therapies. It belongs to a new class of antivirals that target the CMV UL97 protein kinase, thereby inhibiting viral DNA replication and assembly.
Introduction of Maribrook Tablet(Maribavir)
Maribrook Tablet contains maribavir, an antiviral medication used for the treatment of cytomegalovirus (CMV) infection, particularly in transplant patients who are resistant or refractory to other antiviral therapies. It works by inhibiting the CMV UL97 protein kinase, thereby preventing viral replication.
Precautions of Maribrook Tablet(Maribavir)
- Use cautiously in patients with severe liver impairment
- Monitor liver function tests
- Not recommended in pregnancy and breastfeeding unless prescribed
- Caution in patients with hypersensitivity to maribavir
- Monitor for drug resistance
- Use with caution in renal impairment
- Regular monitoring of CMV viral load is required
- Follow strict dose compliance
Uses of Maribrook Tablet(Maribavir)
- Treatment of cytomegalovirus (CMV) infection
- Used in post-transplant patients (solid organ or hematopoietic stem cell)
- Effective in resistant or refractory CMV infections
- Helps reduce viral load
- Prevents progression of CMV disease
- Supports recovery in immunocompromised patients
- Alternative to conventional antivirals
- Improves clinical outcomes in CMV management
Side Effects of Maribrook Tablet(Maribavir)
- Taste disturbance (dysgeusia)
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- Headache
- Abdominal pain
- Increased liver enzymes
FAQs of Maribrook Tablet(Maribavir)
1. What is Maribrook Tablet used for?
Maribrook Tablet is indicated for the treatment of cytomegalovirus (CMV) infection, particularly in adult transplant patients who are resistant or refractory to other antiviral therapies.
2. What is the active ingredient in Maribrook Tablet?
The active ingredient is maribavir, an antiviral agent that specifically targets CMV infection.
3. How does Maribavir work?
Maribavir inhibits the UL97 protein kinase enzyme of CMV, thereby preventing viral replication and reducing viral load.
4. Who should use Maribrook Tablet?
It is primarily prescribed for post-transplant patients (solid organ or hematopoietic stem cell) suffering from CMV infection.
5. What is the recommended dosage of Maribrook Tablet?
The dosage should be taken as prescribed by a healthcare professional, typically based on patient condition and response to therapy.
6. What are the common side effects of Maribrook Tablet?
Common side effects include taste disturbance (dysgeusia), nausea, vomiting, diarrhea, and fatigue.
7. Does Maribrook Tablet interact with other medications?
Yes, it may interact with immunosuppressants, CYP3A substrates, anticonvulsants, and enzyme inducers, requiring monitoring or dose adjustments.
8. Is monitoring required during treatment?
Yes, regular monitoring of CMV viral load and liver function tests is recommended during therapy.
Interactions of Maribrook Tablet(Maribavir)
- Immunosuppressants (e.g., tacrolimus, cyclosporine) – may require dose adjustment
- CYP3A substrates – maribavir may alter drug levels
- Anticonvulsants (e.g., phenytoin, carbamazepine) – may reduce effectiveness
- Herbal products (e.g., St. John’s Wort) – avoid use
- Other antivirals – monitor for additive effects
- Rifampicin – may decrease maribavir levels
- Warfarin – monitor coagulation parameters
- Strong enzyme inducers/inhibitors – caution advised
| Manufacturer | : | Healing Pharma |
| Trade Name | : | |
| Generic Search | : | Maribavir |
| Strength | : | 200mg |
Latest Products
